{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T16:20:51Z","timestamp":1771863651924,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"8","content-domain":{"domain":["ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ejim.2013.05.011","type":"journal-article","created":{"date-parts":[[2013,6,12]],"date-time":"2013-06-12T16:05:25Z","timestamp":1371053125000},"page":"784-790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: A retrospective multi-hospital-based study of 87 Italian cases"],"prefix":"10.1016","volume":"24","author":[{"given":"Olga","family":"Di Fede","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenica","family":"Matranga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Solazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Gabriele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni M.","family":"Gaeta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianfranco","family":"Favia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delia","family":"Sprini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Peluso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Colella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Vescovi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Campisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejim.2013.05.011_bb0005","doi-asserted-by":"crossref","first-page":"672","DOI":"10.12968\/denu.2011.38.10.672","article-title":"A current update on osteonecrosis of the jaw and bisphosphonates","volume":"38","author":"Arrain","year":"2011","journal-title":"Dent Update"},{"key":"10.1016\/j.ejim.2013.05.011_bb0010","author":"Arrigo AONSAeBeC"},{"issue":"34","key":"10.1016\/j.ejim.2013.05.011_bb0015","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejim.2013.05.011_bb0020","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0022034510397196","article-title":"Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN","volume":"90","author":"Barasch","year":"2011","journal-title":"J Dent Res"},{"issue":"4","key":"10.1016\/j.ejim.2013.05.011_bb0025","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.stomax.2010.07.009","article-title":"Jaw osteonecrosis induced by oral biphosphonates: 12 cases","volume":"111","author":"Barrier","year":"2010","journal-title":"Rev Stomatol Chir Maxillofac"},{"issue":"6","key":"10.1016\/j.ejim.2013.05.011_bb0030","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1601-0825.2012.01903.x","article-title":"Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaw (BRONJ)","volume":"18","author":"Bedogni","year":"2012","journal-title":"Oral Dis"},{"issue":"2","key":"10.1016\/j.ejim.2013.05.011_bb0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tripleo.2007.01.040","article-title":"Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer","volume":"104","author":"Bianchi","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.ejim.2013.05.011_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2010.05929.x","article-title":"Bisphosphonates and osteonecrosis of the jaw: proceedings of an international conference","volume":"1218","author":"Bilezikian","year":"2011","journal-title":"Ann N Y Acad Sci"},{"issue":"22","key":"10.1016\/j.ejim.2013.05.011_bb0045","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1056\/NEJMp1202623","article-title":"Continuing bisphosphonate treatment for osteoporosis\u2013for whom and for how long?","volume":"366","author":"Black","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ejim.2013.05.011_bb0050","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/jbmr.1542","article-title":"Bisphosphonate therapy for osteoporosis: the long and short of it","volume":"27","author":"Compston","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.ejim.2013.05.011_bb0055","first-page":"146","article-title":"Osteonecrosis in the jaws of patients who are using oral biphosphonates to treat osteoporosis","volume":"22","author":"Dello Russo","year":"2007","journal-title":"Int J Oral Maxillofac Implants"},{"issue":"5","key":"10.1016\/j.ejim.2013.05.011_bb0060","doi-asserted-by":"crossref","first-page":"751","DOI":"10.4317\/medoral.18041","article-title":"Oral bisphosphonate-related osteonecrosis of the jaws: clinical characteristics of a series of 20 cases in Spain","volume":"17","author":"Diniz-Freitas","year":"2012","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"2","key":"10.1016\/j.ejim.2013.05.011_bb0065","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.mehy.2011.11.011","article-title":"Is oral bisphosphonate-related osteonecrosis of the jaw an endemic condition?","volume":"78","author":"Diz","year":"2012","journal-title":"Med Hypotheses"},{"issue":"10","key":"10.1016\/j.ejim.2013.05.011_bb0070","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archinternmed.2012.340","article-title":"Drug, patient, and physician characteristics associated with off-label prescribing in primary care","volume":"172","author":"Eguale","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2013.05.011_bb0075","author":"EMEA"},{"issue":"12","key":"10.1016\/j.ejim.2013.05.011_bb0080","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.3899\/jrheum.090455","article-title":"Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients","volume":"36","author":"Favia","year":"2009","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.ejim.2013.05.011_bb0085","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.amjmed.2010.04.033","article-title":"Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series","volume":"123","author":"Fedele","year":"2010","journal-title":"Am J Med"},{"issue":"9768","key":"10.1016\/j.ejim.2013.05.011_bb0090","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study","volume":"377","author":"Fizazi","year":"2011","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ejim.2013.05.011_bb0095","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/jbmr.103","article-title":"Prolonged antiresorptive activity of zoledronate: a randomized, controlled trial","volume":"25","author":"Grey","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ejim.2013.05.011_bb0100","author":"ISTAT"},{"issue":"5","key":"10.1016\/j.ejim.2013.05.011_bb0105","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1185\/030079906X100276","article-title":"Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis","volume":"22","author":"Iwamoto","year":"2006","journal-title":"Curr Med Res Opin"},{"issue":"10","key":"10.1016\/j.ejim.2013.05.011_bb0110","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"American Society for Bone and Mineral Research. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.ejim.2013.05.011_bb0115","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1592\/phco.28.5.667","article-title":"Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates","volume":"28","author":"King","year":"2008","journal-title":"Pharmacotherapy"},{"issue":"7","key":"10.1016\/j.ejim.2013.05.011_bb0120","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/pbc.22428","article-title":"Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukaemia (ALL)","volume":"54","author":"Kotecha","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ejim.2013.05.011_bb0125","doi-asserted-by":"crossref","DOI":"10.3109\/00016357.2013.764007","article-title":"Bisphosphonate-related osteonecrosis of the jaw in four Nordic countries and an indication of under-reporting","author":"Kruger","year":"2013","journal-title":"Acta Odontol Scand"},{"issue":"11","key":"10.1016\/j.ejim.2013.05.011_bb0130","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.joms.2009.06.029","article-title":"Risk factors for bisphosphonate-related osteonecrosis of the jaws","volume":"67","author":"Kyrgidis","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"issue":"2","key":"10.1016\/j.ejim.2013.05.011_bb0135","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00198-012-2013-y","article-title":"Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures","volume":"24","author":"Lapi","year":"2013","journal-title":"Osteoporos Int"},{"issue":"5","key":"10.1016\/j.ejim.2013.05.011_bb0140","first-page":"36","article-title":"Bisphosphonates, phossy jaw, and bisphosphonate-related osteonecrosis of the jaw","volume":"102","author":"Lewis","year":"2011","journal-title":"J Okla Dent Assoc"},{"issue":"2","key":"10.1016\/j.ejim.2013.05.011_bb0145","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","article-title":"Predicting Risk of Osteonecrosis of the Jaw with Oral Bisphosphonate Exposure (PROBE) Investigators. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure","volume":"68","author":"Lo","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ejim.2013.05.011_bb0150","doi-asserted-by":"crossref","first-page":"e5988","DOI":"10.1136\/bmj.e5988","article-title":"Osteonecrosis of the jaw is becoming more common","volume":"345","author":"Loukota","year":"2012","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ejim.2013.05.011_bb0155","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00774-011-0299-z","article-title":"An epidemiological study of alendronate-related osteonecrosis of the jaws. A case series from the south-east of Scotland with attention given to case definition and prevalence","volume":"30","author":"Malden","year":"2012","journal-title":"J Bone Miner Metab"},{"issue":"3","key":"10.1016\/j.ejim.2013.05.011_bb0160","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijom.2010.11.002","article-title":"Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis","volume":"40","author":"Manfredi","year":"2011","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"1","key":"10.1016\/j.ejim.2013.05.011_bb0165","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.oraloncology.2011.08.010","article-title":"Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study","volume":"48","author":"Martins","year":"2012","journal-title":"Oral Oncol"},{"issue":"11","key":"10.1016\/j.ejim.2013.05.011_bb0170","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"issue":"9","key":"10.1016\/j.ejim.2013.05.011_bb0175","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.ejim.2013.05.011_bb0180","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","article-title":"Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia","volume":"65","author":"Mavrokokki","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"issue":"2","key":"10.1016\/j.ejim.2013.05.011_bb0185","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.tripleo.2004.10.001","article-title":"Bisphosphonate-associated oral osteonecrosis","volume":"99","author":"Migliorati","year":"2005","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"10.1016\/j.ejim.2013.05.011_bb0190","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1634\/theoncologist.2010-0183","article-title":"Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw","volume":"16","author":"Miksad","year":"2011","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.ejim.2013.05.011_bb0195","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tripleo.2011.02.037","article-title":"Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center","volume":"112","author":"Nicolatou-Galitis","year":"2011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"8","key":"10.1016\/j.ejim.2013.05.011_bb0200","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.joms.2011.08.033","article-title":"Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Oral Bisphosphonate Exposure: Clinical Course and Outcomes","volume":"70","author":"O'Ryan","year":"2012","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"10.1016\/j.ejim.2013.05.011_bb0205","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jcms.2010.05.009","article-title":"Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence\u2013a multi-centre study","volume":"39","author":"Otto","year":"2011","journal-title":"J Craniomaxillofac Surg"},{"issue":"2","key":"10.1016\/j.ejim.2013.05.011_bb0210","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrrheum.2011.181","article-title":"Epidemiology and pathogenesis of osteonecrosis of the jaw","volume":"8","author":"Reid","year":"2012","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"10.1016\/j.ejim.2013.05.011_bb0215","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.oraloncology.2011.01.002","article-title":"Efficacy and safety of medical ozone (O(3)) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: Preliminary results of a phase I-II study","volume":"47","author":"Ripamonti","year":"2011","journal-title":"Oral Oncol"},{"issue":"5","key":"10.1016\/j.ejim.2013.05.011_bb0220","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.bone.2008.01.003","article-title":"Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis","volume":"42","author":"Rizzoli","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.ejim.2013.05.011_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.tripleo.2011.08.016","article-title":"Radiographic evaluation of maxillofacial region in oncology patients treated with bisphosphonates","author":"Rocha","year":"2012","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"3","key":"10.1016\/j.ejim.2013.05.011_bb0230","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1747-4477.2009.00213.x","article-title":"Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update","volume":"35","author":"Ruggiero","year":"2009","journal-title":"Aust Endod J"},{"key":"10.1016\/j.ejim.2013.05.011_bb0235","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev.med.60.063007.134350","article-title":"Bisphosphonate-related osteonecrosis of the jaw:diagnosis, prevention, and management","volume":"60","author":"Ruggiero","year":"2009","journal-title":"Annu Rev Med"},{"issue":"1","key":"10.1016\/j.ejim.2013.05.011_bb0240","doi-asserted-by":"crossref","first-page":"61","DOI":"10.14219\/jada.archive.2009.0019","article-title":"Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: aninstitutional inquiry","volume":"140","author":"Sedghizadeh","year":"2009","journal-title":"J Am Dent Assoc"},{"issue":"2 Suppl.","key":"10.1016\/j.ejim.2013.05.011_bb0245","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.amjmed.2008.12.005","article-title":"Osteonecrosis of the jaw and the role of bisphosphonates: a critical review","volume":"122","author":"Silverman","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2013.05.011_bb0250","author":"Sottosanti"},{"issue":"35","key":"10.1016\/j.ejim.2013.05.011_bb0255","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study","volume":"28","author":"Stopeck","year":"2010","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejim.2013.05.011_bb0260","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/annonc\/mdr039","article-title":"Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience","volume":"23","author":"Vandone","year":"2012","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.ejim.2013.05.011_bb0265","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.oraloncology.2010.11.007","article-title":"Surgery-triggered and non surgery-triggered Bisphosphonate-related Osteonecrosis of the Jaws (BRONJ): A retrospective analysis of 567 cases in an Italian multicenter study","volume":"47","author":"Vescovi","year":"2011","journal-title":"Oral Oncol"},{"issue":"3","key":"10.1016\/j.ejim.2013.05.011_bb0270","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0714.2011.01091.x","article-title":"Bisphosphonates-related osteonecrosis of the jaws: a concise review of the literature and a report of a single-centre experience with 151 patients","volume":"41","author":"Vescovi","year":"2012","journal-title":"J Oral Pathol Med"},{"issue":"5","key":"10.1016\/j.ejim.2013.05.011_bb0275","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.eururo.2008.06.070","article-title":"Prevalence and Risk Factors of Bisphosphonate-Associated Osteonecrosis of the Jaw in Prostate Cancer Patients with Advanced Disease Treated with Zoledronate","volume":"54","author":"Walter","year":"2008","journal-title":"Eur Urol"},{"issue":"22","key":"10.1016\/j.ejim.2013.05.011_bb0280","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1056\/NEJMp1202619","article-title":"Bisphosphonates for osteoporosis\u2013where do we go from here?","volume":"366","author":"Whitaker","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejim.2013.05.011_bb0285","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.bone.2012.08.115","article-title":"Risk of osteomyelitis of the jaw induced by oral bisphosphonates in patients taking medications for osteoporosis: a hospital-based cohort study in Japan","volume":"51","author":"Yamazaki","year":"2012","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.ejim.2013.05.011_bb0290","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00198-007-0384-2","article-title":"Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome","volume":"18","author":"Yarom","year":"2007","journal-title":"Osteoporos Int"},{"issue":"12","key":"10.1016\/j.ejim.2013.05.011_bb0295","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral Bisphosphonate-Induced Osteonecrosis: Risk Factors, Prediction of Risk Using Serum CTX Testing, Prevention, and Treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"10.1016\/j.ejim.2013.05.011_bb0300","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.joms.2008.11.015","article-title":"Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients","volume":"67","author":"Lazarovici","year":"2009","journal-title":"J Oral Maxillofac Surg"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513001398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513001398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T23:50:48Z","timestamp":1645746648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620513001398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0953620513001398"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2013.05.011","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: A retrospective multi-hospital-based study of 87 Italian cases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2013.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}